Gelesis Holdings, Inc.

NYSE
GLS
Stock
Yield per half year: -94.93%
Dividend yield: 0%
Sector: Healthcare

Gelesis Holdings, Inc.

0.01350.01350.01080.01080.00810.00810.00540.00540.00270.00270.00000.000012 Sep12 Sep13 Sep13 Sep14 Sep14 Sep15 Sep15 Sep16 Sep16 Sep17 Sep17 Sep18 Sep18 Sep19 Sep19 Sep20 Sep20 Sep21 Sep21 Sep22 Sep22 Sep23 Sep23 Sep24 Sep24 Sep25 Sep25 Sep26 Sep26 Sep27 Sep27 Sep28 Sep28 Sep29 Sep29 Sep30 Sep30 SepOct '24Oct '24

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 29.26 -100% 0 0%
P/S 2.13 3.99 -46.65%
P/BV 3.68 10.48 -64.9%
P/FCF 0 37.19 -100%
Ev/Ebitda -0.65 18.36 -103.54%
Ev/S 2.22 4.31 -48.56%
Ev/FCF 0 46.13 -100%
E/P -1.86 0.1739 -1169.85%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-423.85 21.35 -2084.81% -529.17 -19.9%
ROE -552.36 -73.65 649.97%
ROA -51.79 6.71 -871.77%
ROIC 0 21.56 -100%
ROS -172.31 10.72 -1707.68%
ROCE 0 83.22 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.5309 2.73 -119.44% -0.5867 -9.51%
Nеt Debt/Ebitda 0 2.87 -100%
Debt/Ratio 0 0.2923 -100%
Debt/Equity 0 14.93 -100%
Debt/Net Income -1.31 5.02 -126.01%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.3 -100% 0 0%
Number of years of dividend growth 0 6.36 -100%
DSI 0 0.7363 -100%
Average dividend growth 0 -7.81 -100%
Average percentage for 5 years 0 1.29 -100%
Average percentage for payments 0 42.3 -100%
Difference from average difference in sector -1.3

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
4/10
21.26 1169.02 -98.18%
Growth impulse Ebitda in 5 years 36.85 151.11 -75.61%
Growth impulse Net Income in 5 years 153.82 10125.27 -98.48%
Growth impulse FCF in 5 years 15.48 5781.14 -99.73%
Growth impulse EPS in 5 years -84.21 13603.5 -100.62%
IP Score
3.93/10

Similar companies

Bristol-Myers

Humana

UnitedHealth Group

AbbVie

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription